Acasă › Cancer pulmonar cu celule mici › Tennessee › Nashville
Studii clinice pentru Cancer pulmonar cu celule mici în Nashville, TN
20 studii pentru Cancer pulmonar cu celule mici caută participanți în și în jurul orașului Nashville (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Sarah Cannon Research Institute, Nashville
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
În curs de recrutareFaza 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute (SCRI), Nashville
DESTINY-PANTUMOUR04
În curs de recrutareStudiu observațional
- Research Site, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
În curs de recrutareFaza 1/2
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
În curs de recrutareFaza 3
- SCRI Oncology Partners /ID# 279779, Nashville
- Vanderbilt University Medical Center /ID# 280169, Nashville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon - Tennessee Oncology, Nashville
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- SCRI Oncology Partners, Nashville
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
În curs de recrutareFaza 3
- SCRI OP (Oncology Partners), Nashville
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
În curs de recrutareFaza 3
- SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
În curs de recrutareFaza 1/2
- Sarah Cannon Research Institute ( Site 7001), Nashville
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
În curs de recrutareFaza 1/2
- SCRI Oncology Partners, Nashville
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
În curs de recrutareFaza 1
- Sarah Cannon Research Institute (SCRI), Nashville
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
În curs de recrutareFaza 2
- SCRI Oncology Partners, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
În curs de recrutareFaza 1
- Tennessee Oncology, PLLC, Nashville
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- Sarah Cannon Research Institute - Oncology Partners, Nashville
A Study of LY4175408 in Participants With Advanced Cancer
În curs de recrutareFaza 1
- Sarah Cannon Research Institute, Nashville
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Research Site 136, Nashville
Studii pentru Cancer pulmonar cu celule mici în alte orașe
- Houston, TX26 studii
- Arlington, VA23 studii
- New York City, NY22 studii
- Boston, MA21 studii
- Los Angeles, CA20 studii
- Orlando, FL15 studii
- Dallas, TX13 studii
- Cleveland, OH13 studii
- Chicago, IL13 studii
- St. Louis, MO13 studii
- Detroit, MI12 studii
- Washington, DC12 studii
Alte studii în Nashville
- Cancer pulmonar cu celule non-pătrate97 studii
- Cancer de sân81 studii
- Cancer metastatic70 studii
- Cancer colorectal69 studii
- Cancer (toate tipurile)65 studii
- Cancer ovarian49 studii
- Cancer de prostată43 studii
- Cancer pulmonar40 studii
- Carcinom cu celule scuamoase de cap și gât39 studii
- Cancer pancreatic39 studii
- Cancer endometrial38 studii
- Melanom33 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.